Test Evidence-Based Strategies for Selecting and Sequencing Systemic Therapies in RCC: Highlights From ASCO GU 2022 and Beyond
home / peer-exchange / test-evidence-based-strategies-for-selecting-and-sequencing-systemic-therapies-in-rcc-highlights
A panel of experts discuss renal cell carcinoma (RCC) using evidence-based data presented at the ASCO GU 2022 Annual Meeting this year.
New content coming soon.
